Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection
- PMID: 20641038
- PMCID: PMC2996086
- DOI: 10.1002/stem.471
Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection
Figures
References
-
- Bueno C, Catalina P, Melen GJ, et al. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis. 2009;30:1628–1637. - PubMed
-
- Bueno C, Garcia-Castro J, Montes R, et al. Human embryonic stem cells: A potential system for modeling infant leukemia harboring MLL-AF4 fusion gen. Drug Dis Today: Dis Models. 2008;4:53–59.
-
- Menendez P, Bueno C, Wang L. Human embryonic stem cells: A journey beyond cell replacement therapies. Cytotherapy. 2006;8:530–541. - PubMed
-
- Menendez P, Bueno C, Wang L, et al. Human embryonic stem cells: Potential tool for achieving immunotolerance? Stem Cell Rev. 2005;1:151–158. - PubMed
-
- Przyborski SA. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells. 2005;23:1242–1250. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
